M70800
3-甲基-1-苯基-2-吡唑啉-5-酮
99%, for peptide synthesis
别名:
依达拉奉, 5-甲基-2-苯基-2,4-二氢-3-H-吡唑-3-酮
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C10H10N2O
化学文摘社编号:
分子量:
174.20
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352005
EC Number:
201-891-0
MDL number:
Beilstein/REAXYS Number:
609575
产品名称
3-甲基-1-苯基-2-吡唑啉-5-酮, 99%
Quality Level
assay
99%
form
powder, crystals or chunks
bp
287 °C/265 mmHg (lit.)
mp
126-128 °C (lit.)
application(s)
peptide synthesis
SMILES string
CC1=NN(C(=O)C1)c2ccccc2
InChI
1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3
InChI key
QELUYTUMUWHWMC-UHFFFAOYSA-N
Application
3-甲基-1-苯基-2-吡唑啉-5-酮可用于：
- ESI/MALDI-MS检测还原性碳水化合物的试剂
- 提高还原性单糖和寡糖的敏感性，便于随后用毛细管区带电泳进行测定
- 在用高效液相色谱（HPLC）分析之前，对 丹参、盐酸川芎嗪和葡萄糖注射液中单糖组分进行柱前衍生化。
ESI/MALDI -MS检测还原性碳水化合物的试剂。
Still not finding the right product?
Explore all of our products under 3-甲基-1-苯基-2-吡唑啉-5-酮
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2
存储类别
11 - Combustible Solids
wgk
WGK 1
ppe
dust mask type N95 (US), Eyeshields, Gloves
商品
蛋白质的结构修饰对于活细胞是必不可少的。发生调节异常时，它们往往是会引发疾病。聚糖是生物系统中许多结构变异的原因，它们在细胞表面的表现通常被称为“糖”。
Glycans play a key role in protein structure and disease; representation on cell surfaces is the glycome.
Fa-Huan Ge et al.
Journal of analytical methods in chemistry, 2017, 9245620-9245620 (2017-05-11)
Salvia miltiorrhiza, liguspyragine hydrochloride, and glucose injection (SLGI) was made of Salvia miltiorrhiza Bge., liguspyragine hydrochloride, glucose, and glycerin. There were many kinds of monosaccharide components in SLGI, which might be from the raw material and Salvia miltiorrhiza Bge. Separation
Xian-Wen Yang et al.
Journal of natural products, 70(4), 521-525 (2007-03-09)
Six new mixed lignan-neolignans and 20 known compounds were isolated from the whole plant of Tarenna attenuata. By analysis of physical and spectroscopic data, the structures of the new compounds were elucidated as (1R,5R,6R)-6-{4-O-[2-(1-(4-hydroxy-3-methoxyphenyl))glycerol]-3,5-dimethoxyphenyl}-3,7-dioxabicyclo[3.3.0]octan-2-one (1), 5' '-methoxyhedyotisol A (2), 4'
Konstantin Chegaev et al.
Journal of medicinal chemistry, 52(2), 574-578 (2008-12-31)
A new series of polyvalent drugs obtained by joining edaravone with NO-donor moieties is described. All compounds display high antioxidant power together with NO-dependent vasodilator properties. The analysis of a number of molecular descriptors shows that the antioxidant activity, which
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| M70800-100G | 04061834061618 |
| M70800-500G | 04061834061625 |
| M70800-5G | 04061834061632 |